About the Authors

Sheila Weinmann

Sheila.Weinmann@kpchr.org

Affiliation The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, United States of America

Allison Naleway

Affiliation The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, United States of America

Geeta Swamy

Affiliation Department of Obstetrics & Gynecology, Duke University Medical Center, Durham, North Carolina, United States of America

Girishanthy Krishnarajah

Current address: Health Economics & Reimbursement Strategy, CSL, King of Prussia, Pennsylvania, United States of America

Affiliation US Health Outcomes and Medical Policy, GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America

Bhakti Arondekar

Current address: Global Health & Value, Pfizer, Collegeville, Pennsylvania, United States of America

Affiliation US Health Outcomes and Medical Policy, GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America

Jovelle Fernandez

Current address: Japan Medical Office & Global Medical Affairs-Japan, Takeda, Tokyo, Japan

Affiliation North American Vaccine Development, GlaxoSmithKline Biologicals, Philadelphia and King of Prussia, Pennsylvania, United States of America

Evan Myers

Affiliation Department of Obstetrics & Gynecology, Duke University Medical Center, Durham, North Carolina, United States of America

Competing Interests

S Weinmann, A Naleway, E Myers, G Swamy (and/or their institutions) received funding from the GSK group of companies to complete the work disclosed in this manuscript (for study design, model development, statistical analysis). G Swamy declares to have received consulting and lecturing fees and grant support for vaccine studies from GSK, as well as for advisory boards, lectures, and the development of educational presentations. E Myers declares to have received consulting fees from the GSK group of companies, Merck and Gen-Probe. G Krishnarajah, B Arondekar and J Fernandez were employees of the GSK group of companies at the time of the study conduct and own restricted shares/stocks of the GSK group of companies. G Krishnarajah is currently employed by CSL and also reports ownership of stock options/restricted shares from CSL. B Arondekar is currently employed by Pfizer. J Fernandez is currently employed by Takeda and also reports ownership of stock options/restricted shares from Takeda. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: SW AN GS GK BA JF EM. Data curation: SW AN. Formal analysis: SW AN. Funding acquisition: GK BA JF. Investigation: SW AN. Methodology: SW AN GS GK BA JF EM. Project administration: SW GK. Resources: SW AN. Software: SW AN. Supervision: SW. Validation: SW AN. Writing – original draft: SW. Writing – review & editing: SW AN GS GK BA JF EM.